RETRACTED: Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease

Claire Bordat, Elie Nader, Philippe Connes, Philippe Joly, Solene Poutrel, Anne Perez, Eric Niesor

Open source

DOI
10.1177/13860291251320332
Published
2025-04
Container
Clinical Hemorheology and Microcirculation
Publisher
SAGE Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/13860291251320332,
  title = {RETRACTED: Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease},
  author = {Claire Bordat and Elie Nader and Philippe Connes and Philippe Joly and Solene Poutrel and Anne Perez and Eric Niesor},
  year = {2025},
  journal = {Clinical Hemorheology and Microcirculation},
  doi = {10.1177/13860291251320332},
  url = {https://doi.org/10.1177/13860291251320332}
}

RIS

TY  - JOUR
TI  - RETRACTED: Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease
AU  - Claire Bordat
AU  - Elie Nader
AU  - Philippe Connes
AU  - Philippe Joly
AU  - Solene Poutrel
AU  - Anne Perez
AU  - Eric Niesor
PY  - 2025
JO  - Clinical Hemorheology and Microcirculation
DO  - 10.1177/13860291251320332
UR  - https://doi.org/10.1177/13860291251320332
ER  - 

APA

Bordat, C., Nader, E., Connes, P., Joly, P., Poutrel, S., Perez, A., & Niesor, E. (2025). RETRACTED: Effect of dalcetrapib, voxelotor and their combination on red blood cell deformability and sickling in sickle cell disease. Clinical Hemorheology and Microcirculation. https://doi.org/10.1177/13860291251320332

Source records